Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort Once Daily in Asthma (STEM)
NCT00652392Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2003
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of budesonide + formoterol in asthma, sponsored by AstraZeneca. Started Apr 2003; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00652392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652392.